Our research group has been established in 2013 by György M. Keserű on the basis of a preceding synthetic organic chemistry group. Since then we established national and international, government and industry founded research programs focusing on the following major topics:

  • fragment based approaches in the lead discovery of GPCR and kinase targets
  • chemical process development for small molecule active pharmaceutical ingredients
  • design and synthesis of targeted covalent inhibitors (TCIs)

You can follow us on Twitter, and view our archived news page here.

Funding agencies